Credit Agricole
IONS icon

Credit Agricole’s Ionis Pharmaceuticals IONS Stock Holding History

Credit Agricole’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Hold
4,410
– – ﹤0.01% 1257
2026
Q1 		$331K Hold
4,410
– – ﹤0.01% 1224
2025
Q4 		$349K Sell
4,410
-300
-6% -$22.6K ﹤0.01% 1186
2025
Q3 		$308K Buy
+4,710
New +$230K ﹤0.01% 1069
2021
Q3 		– Sell
-4,210
Closed -$168K – 701
2021
Q2 		$168K Hold
4,210
– – ﹤0.01% 377
2021
Q1 		$189K Buy
4,210
+3,540
+528% +$197K ﹤0.01% 336
2020
Q4 		$38K Hold
670
– – ﹤0.01% 420
2020
Q3 		$32K Hold
670
– – ﹤0.01% 393
2020
Q2 		$40K Hold
670
– – ﹤0.01% 338
2020
Q1 		$32K Buy
670
+170
+34% +$9.47K ﹤0.01% 347
2019
Q4 		$30K Hold
500
– – ﹤0.01% 337
2019
Q3 		$30K Hold
500
– – ﹤0.01% 401
2019
Q2 		$32K Hold
500
– – ﹤0.01% 397
2019
Q1 		$41K Buy
+500
New +$32.3K ﹤0.01% 388
2016
Q4 		– Sell
-4,600
Closed -$168K – 1508
2016
Q3 		$168K Sell
4,600
-15,551
-77% -$487K ﹤0.01% 1469
2016
Q2 		$470K Hold
20,151
– – ﹤0.01% 1187
2016
Q1 		$816K Buy
20,151
+2,000
+11% +$81.2K ﹤0.01% 965
2015
Q4 		$1.12M Buy
18,151
+1,906
+12% +$103K 0.01% 977
2015
Q3 		$656K Hold
16,245
– – ﹤0.01% 1101
2015
Q2 		$935K Buy
16,245
+1,100
+7% +$69.9K ﹤0.01% 1054
2015
Q1 		$965K Buy
15,145
+12,545
+483% +$851K ﹤0.01% 1081
2014
Q4 		$178K Buy
+2,600
New +$128K ﹤0.01% 1417
2014
Q3 		– Sell
-570
Closed -$20K – 1598
2014
Q2 		$20K Buy
570
+140
+33% +$4.41K ﹤0.01% 1552
2014
Q1 		$19K Sell
430
-1,696
-80% -$82.2K ﹤0.01% 1493
2013
Q4 		$85K Buy
2,126
+124
+6% +$4.42K ﹤0.01% 1386
2013
Q3 		$75K Buy
+2,002
New +$59.8K ﹤0.01% 1438

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Credit Agricole's IONS Position: Q2 2026 in Review

Credit Agricole held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 4,410 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Credit Agricole first reported a position in IONS in Q3 2013 and has held it in 26 quarters since. The position peaked at $1.12M in Q4 2015. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Credit Agricole held 4,410 shares of Ionis Pharmaceuticals worth $350K as of Q2 2026.
  • Credit Agricole left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1257 holding.
  • Credit Agricole first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 26 quarters since.
  • Credit Agricole's Ionis Pharmaceuticals position peaked at $1.12M in Q4 2015.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.